Multiple primary malignancies in patients with sporadic pancreatic endocrine tumors

Journal of Surgical Oncology

Volumn 97, Issue 7, 2008, Pages 592-595

  Fendrich, Volker ^a   Waldmann, Jens ^a   Bartsch, Detlef K ^b   Schlosser, Katja ^a   Rothmund, Matthias ^a   Gerdes, Berthold ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Department of Visceral Surgery   (Germany)

Author keywords

Multiple primary malignancies; Neuroendocrine pancreatic tumors

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GASTRINOMA; GERMANY; HUMAN; INSULINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CANCER; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SEX RATIO;

ADOLESCENT; ADULT; AGED; CARCINOMA, NEUROENDOCRINE; CHILD; FEMALE; GASTRINOMA; HUMANS; INSULINOMA; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PANCREATIC NEOPLASMS;

EID: 44849090144     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21044     Document Type: Article

References (21)

1. Dores GM, Metayer C, Curtis RE, et al.: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 2002; 20:3484-3494.
2. Travis LB, Fossa SD, Schonfeld SJ, et al.: Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 2005;97:1354-1365.
3. Kobayashi Y, Arimoto H, Watanabe S: Occurrence of multiple primary cancer at the National Cancer Center Hospital 1962-1989. Jpn J Clin Oncol 1991;21:233-251.
4. Flannery JT, Boice JD, Jr., Devesa SS, et al.: Cancer registration in Connecticut and the study of multiple primary cancers, 1935-82. Natl Cancer Inst Monogr 1985;68:13-24.
5. Öberg K, Eriksson B: Endocrine tumors of the pancreas. Best Pract Res Clin Gastroenterol 2005;19:753-781.
6. Fendrich V, Langer P, Celik I, et al.: An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 2006;244:845-853.
7. Gerstle JT, Kauffman GL, Jr., Koltun WA: The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg 1995;180:427-432.
8. Brune M, Gerdes B, Koller M, et al.: Neuroendocrine tumors of the gastrointestinal tract (NETGI) and second primary malignancies - Which is dominant? Dtsch Med Wochenschrift 2003; 128:2413-2417.
9. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
10. Moertel CG, Sauer WG, Dockerty MB, et al.: Life history of the carcinoid tumor of the small intestine. Cancer 1961;14:901-912.
11. Gerdes B, Ziegler A, Ramaswamy A, et al.: Multiple primaries in pancreatic cancer patients: Indicator of a genetic predisposition? Int J Epidemiol 2000;29:999-1003.
12. Habal N, Sims C, Bilchik AJ: Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000;75:310-316.
13. Zucker KA, Longo WE, Modlin IM, et al.: Malignant diathesis from jejuno-ileal carcinoids. Am J Gastroenterol 1989;84:182-186.
14. Dockray GJ: Clinical endocrinology and metabolism. Gastrin Best Pract Res Clin Endocrinol Metab 2004;18:555-568.
15. Bold RJ, Ishizuka J, Townsend CM, Jr., et al.: Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B. Biochem Biophys Res Commun 1994;202: 1222-1226.
16. Thorburn CM, Friedman GD, Dickinson CJ, et al.: Gastrin and colorectal cancer: A prospective study. Gastroenterology 1998; 115:275-280.
17. Koh TJ, Chen D: Gastrin as a growth factor in the gastrointestinal tract. Regul Pept 2000;93:37-44.
18. Yu F, Venzon DJ, Serrano J, et al.: Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 1999;17:615-630.
19. Zikusoka MN, Kidd M, Eick G, et al.: The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005;104: 2292-2309.
20. Belfiore A: The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 2007; 13:671-686.
21. Moschos SJ, Mantzoros CS: The role of the IGF system in cancer: From basic to clinical studies and clinical applications. Oncology 2002;63:317-332.